Abnormal accumulation of palmitic acid can increase Akt and RIPK1 palmitoylation by increasing ZDHHC17/24 and ZDHHC5, respectively, thereby exacerbating hepatocyte death, liver injury, and fibrosis formation in MASH mice. Here, AKT1 is linked to metabolic dysfunction-associated steatohepatitis.